In biliary tract cancers, elevated serum CCL23 predicted a dismal prognosis [35], and PEA-measured high plasma CCL28 levels implied worse survival in epithelial ovarian cancers [36]. This evidence concerns the gene CCL28 and biliary tract cancer.